Remove 2029 Remove Disease Remove Regulations Remove Research
article thumbnail

Genomics/Biobanks/Cohort Studies

Broad Institute

Known to be a regulator of metabolism, we have found that in addition it has profound behavioral effects in animals and humans, even evident in population-level economic behavior. The Sabatini Lab focuses on the development and regulation of synapses in the brain and the relationship of these processes to behavior and disease.

article thumbnail

Article FDA Thank You Diagnostics landscape analysis: Key issues and a look ahead at 2024

Agency IQ

Diagnostics landscape analysis: Key issues and a look ahead at 2024 Diagnostic regulation in the U.S. Following significant policy proposals in recent years, 2024 is gearing up to be a profoundly impactful year for diagnostics developers and the policymakers who regulate them. is a constantly evolving topic. In the U.S., In the U.S.,

FDA 40
article thumbnail

The politics of health: How 2024 elections will impact life sciences

Drug Discovery World

This, coupled with looming patent expirations, the impact of new drug pricing regulations, and tighter universal regulation of medical devices presents a complex environment for both large and small life science companies. With an anticipated annual growth rate of 7.61%, they are predicted to reach US$12.57bn by 2029.

Science 130